Study details
Enrolling now
A Study of [14C]-LY4064809 in Healthy Participants
Eli Lilly and Company
NCT IDNCT07519525ClinicalTrials.gov data as of Apr 2026
Phase
Phase 1
Ages
18–55
Locations
1 site in WI
About this study
This Phase 1 study is focused on people with healthy volunteers.
Based on ClinicalTrials.gov records.
PhasePhase 1
Participation effort
Estimated from trial records. Details can vary by site.
Time + visits
Low15%
Logistics
Moderate50%
Logistics difficulty varies by site location and availability.
Trial highlights
Treatment details
Auto-extracted from trial records to preview treatments and outcomes.
Endpoints
Secondary: PK of Total Radioactivity: Plasma Area Under the Concentration Versus Time Curve (AUC) of [14C]-LY4064809, Pharmacokinetics (PK): Plasma Maximum Concentration (Cmax) of LY4064809